We strongly advise to harness Willow Biosciences fundamental analysis to find out if markets are presently mispricing the firm. Specifically this technique allows you to validate available financial indicators of Willow Biosciences as well as the relationship between them. We were able to break down and interpolate data for thirty-two available indicators for Willow Biosciences, which can be compared to its rivals. The stock experiences a very speculative upward sentiment. Check odds of Willow Biosciences to be traded at C$0.0712 in 90 days. Key indicators impacting Willow Biosciences' financial strength include:
Understanding current and past Willow Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Willow Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Willow Biosciences' assets may result in an increase in income on the income statement.
Willow Biosciences competes with Cardiol Therapeutics. Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. WILLOW BIOSCIENCES is traded on Toronto Stock Exchange in Canada.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Willow Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Willow Stock, because this is throwing your money away. Analyzing the key information contained in Willow Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Willow Biosciences Key Financial Ratios
Willow Biosciences' financial ratios allow both analysts and investors to convert raw data from Willow Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Willow Biosciences over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Willow Biosciences's current stock value. Our valuation model uses many indicators to compare Willow Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Willow Biosciences competition to find correlations between indicators driving Willow Biosciences's intrinsic value. More Info.
Willow Biosciences is rated fourth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Willow Biosciences' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Willow Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Willow Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Willow Biosciences Systematic Risk
Willow Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Willow Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Willow Biosciences correlated with the market. If Beta is less than 0 Willow Biosciences generally moves in the opposite direction as compared to the market. If Willow Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Willow Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Willow Biosciences is generally in the same direction as the market. If Beta > 1 Willow Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Willow Biosciences Other Current Liab Over Time
Today, most investors in Willow Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Willow Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Willow Biosciences growth as a starting point in their analysis.
Willow Biosciences December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Willow Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Willow Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Willow Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Willow Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Willow Biosciences's daily price indicators and compare them against related drivers.
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.